(Q28217291)

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Behavioral characterization of neuropeptide Y knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Emerging functions for neuropeptide Y5 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structures to the neuropeptide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The anatomy of neuropeptide-Y-containing neurons in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Agouti and agouti-related protein: analogies and contrasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Leptin activates hypothalamic CART neurons projecting to the spinal cord.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y: A hypothalamic brake restraining the onset of puberty in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Endocrine function of neuropeptide Y knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

A receptor subtype involved in neuropeptide-Y-induced food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y functions as a neuroproliferative factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Pyrazolecarboxamide human neuropeptide Y5 receptor ligands with in vivo antifeedant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Role of the Y5 neuropeptide Y receptor in feeding and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Role of the Y5 neuropeptide Y receptor in limbic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Pharmacological characterization of the cloned neuropeptide Y y(6) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Regional distribution of Y-receptor subtype mRNAs in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

[D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Obesity and the regulation of energy balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The role of neuropeptide Y in the antiobesity action of the obese gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Role of melanocortins in the central control of feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Cloning and expression of a novel neuropeptide Y receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Central nervous system pharmacology of neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Expression of the human neuropeptide tyrosine Y1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The role of NPY in metabolic homeostasis: implications for obesity therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9

Fasting, Leptin Treatment, and Glucose Administration Differentially Regulate Y1 Receptor Gene Expression in the Hypothalamus of Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901427-9